Literature DB >> 15374552

Factors influencing time of intubation with a lightwand device in patients without known airway abnormality.

Shu-Yam Wong1, Nesil Deger Coskunfirat, Hwan-Ing Hee, Jihn-Yih Li, Chit Chen, Chi-Hao Tseng.   

Abstract

STUDY
OBJECTIVE: To evaluate the correlation between accepted screening tests for difficult tracheal intubation and ease of intubation with a lightwand blind technique.
DESIGN: Prospective study.
SETTING: Anesthetic rooms of a university hospital. PATIENTS: 122 female, ASA physical status I, II, and III patients requiring tracheal intubation for elective surgery.
INTERVENTIONS: After receiving a standardized anesthetic induction, patients first underwent direct laryngoscopy to determine Cormack laryngoscopy grade, then tracheal intubation was performed using a transillumination method.
MEASUREMENTS AND MAIN RESULTS: Patient demographics, Mallampati class (MC), mouth opening (MO; cm), and thyromental distance (TMD; cm) were all measured and the values recorded. Body mass index (BMI; kg/m2) was calculated for each patient. Laryngoscopy grades obtained by laryngoscopy were also recorded. Times to intubation were measured by a chronometer and failures were recorded. Patients were then allocated to groups according to the measured parameters: BMI > or = 30 kg/m2, BMI < 30 kg/m2; TMD > or = 6 cm, TMD < 6 cm; MO > or = 3, MO < 3; MC I, MC II, MC III, MC IV, and Laryngoscopy Grade (LG) 1, LG 2, LG 3, LG 4. Intubation times at the first attempt were compared within the groups for each variable. The total results of 119 patients were studied; overall success was 99%, and mean time to intubation at the first attempt was 9.2 +/- 4.9 seconds. Although time to intubation was prolonged with increasing Mallampati and laryngoscopy scores, and in the TMD < 6 cm and BMI > or = 30 kg/m2 groups, only the MC III and BMI > or = 30 kg/m2 groups represented a statistically significant difference of prolongation. Mean time to intubation in the MC III and BMI > or = 30 kg/m2 groups were 13.2 +/- 5.4 (p = 0.011) and 14.8 +/- 1.7 (p < or = 0.001), respectively.
CONCLUSION: Mallampati class III airway significantly increases time to intubation when the transillumination technique is used. BMI > or = 30 kg/m2 is another factor that interferes with the ease and success of intubation with this technique. Copyright 2004 Elsevier Inc.

Entities:  

Mesh:

Year:  2004        PMID: 15374552     DOI: 10.1016/j.jclinane.2003.09.017

Source DB:  PubMed          Journal:  J Clin Anesth        ISSN: 0952-8180            Impact factor:   9.452


  5 in total

1.  Effect-site concentration of remifentanil for blunting hemodynamic responses to tracheal intubation using light wand during target controlled infusion-total intravenous anesthesia.

Authors:  Jun Heum Yon; Jae Keun Jo; Young-Suk Kwon; Hae-Gyun Park; Sangseok Lee
Journal:  Korean J Anesthesiol       Date:  2011-06-17

2.  Encountering unexpected difficult airway: relationship with the intubation difficulty scale.

Authors:  Wonuk Koh; Hajung Kim; Kyongsun Kim; Young-Jin Ro; Hong-Seuk Yang
Journal:  Korean J Anesthesiol       Date:  2016-06-01

3.  Comparison between use of single lightwand and video laryngoscope-guided lightwand for tracheal intubation in simulated cervical spine-immobilized patients: a single-blind randomized study.

Authors:  Ha Yeon Kim; Eun Jung Kim; Hei Jin Yoon; Byungwoong Ko; Seung Yeon Choi; Bon-Nyeo Koo
Journal:  J Int Med Res       Date:  2019-09-25       Impact factor: 1.671

4.  The clinical effective dose of rocuronium for lightwand tracheal intubation after induction with alfentanil, propofol, and low concentrations of sevoflurane.

Authors:  Hee-Yeon Park; Dongchul Lee; Kyung-Cheon Lee; Seung-Hwan Kim
Journal:  Korean J Anesthesiol       Date:  2010-08-20

5.  Relevance of radiological and clinical measurements in predicting difficult intubation using light wand (Surch-lite™) in adult patients.

Authors:  Joungmin Kim; Kyong Shil Im; Jae Myeong Lee; Jaehun Ro; Kyung Yeon Yoo; Jong Bun Kim
Journal:  J Int Med Res       Date:  2015-12-07       Impact factor: 1.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.